Pembrolizumab (MK-3475) for patients (pts) with advanced esophageal carcinoma: Preliminary results from KEYNOTE-028.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pembrolizumab (MK-3475) for patients (pts) with advanced esophageal carcinoma: Preliminary results from KEYNOTE-028.

Published:2015-05-20 Issue:15_suppl Volume:33 Page:4010-4010
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Doi Toshihiko¹,Piha-Paul Sarina Anne²,Jalal Shadia Ibrahim³,Mai-Dang Hieu⁴,Yuan Sammy⁴,Koshiji Minori⁴,Csiki Ildiko⁴,Bennouna Jaafar⁵

Affiliation:

1. National Cancer Center Hospital East, Chiba, Japan

2. Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, TX

3. Indiana University School of Medicine, Indianapolis, IN

4. Merck & Co., Inc., Kenilworth, NJ

5. Institut de Cancérologie de l'Ouest, Nantes, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2015.33.15_suppl.4010

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First report of a very rare complication in a case of nonsmall cell lung carcinoma;Breathe;2021-12

2. Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy;Frontiers in Immunology;2021-04-28

3. Immunotherapy in Esophageal Cancer;Esophageal Cancer;2019-12-01

4. The Current Status of Immunotherapies in Esophagogastric Cancer;Hematology/Oncology Clinics of North America;2019-04

5. Esophageal and Gastroesophageal Junction Tumors;Textbook of Gastrointestinal Oncology;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP